ConductScience.org, home

Paper42606187

Epigenetic Factor Dysregulation and Distinct Expression Signatures in Retinoblastoma: A Transcriptomic Analysis.

Jha GK and 4 others. Invest Ophthalmol Vis Sci, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Epigenetic Factor Dysregulation and Distinct Expression Signatures in Retinoblastoma: A Transcriptomic Analysis. Papers, record 42606187. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42606187

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epigenetic Factor Dysregulation and Distinct Expression Signatures in Retinoblastoma: A Transcriptomic Analysis.
PubMed
Journal
Invest Ophthalmol Vis Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-22
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jha GKGaurab Kumar
2Fatima AAzima
3Srivastava AAlok
4Kaliki SSwathi
5Pallavi RRani

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RetinoblastomaMajor topic
Retinal NeoplasmsMajor topic
Epigenesis, GeneticMajor topic
Gene Expression Regulation, NeoplasticMajor topic
TranscriptomeMajor topic
Humans
Gene Expression Profiling

Source PubMed

Download CSV of topics

References85

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135839812The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.Lancet Glob Health2022https://conductscience.org/library/papers/35839812PubMed
217483501Sparse non-negative matrix factorizations via alternating non-negativity-constrained least squares for microarray data analysis.Bioinformatics2007https://conductscience.org/library/papers/17483501PubMed
330779712Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.JCI Insight2019https://conductscience.org/library/papers/30779712PubMed
439566382ANP32E promotes esophageal cancer progression and paclitaxel resistance via P53/SLC7A11 axis-regulated ferroptosis.Int Immunopharmacol2025https://conductscience.org/library/papers/39566382PubMed
530180179Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.PLoS One2018https://conductscience.org/library/papers/30180179PubMed
636212776Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors.Mol Ther Oncolytics2022https://conductscience.org/library/papers/36212776PubMed
739844453edgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets.Nucleic Acids Res2025https://conductscience.org/library/papers/39844453PubMed
840234378VRK1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma mediated by SNAI1 via phosphorylating CHD1L.Cell Death Dis2025https://conductscience.org/library/papers/40234378PubMed
938572059p160 nuclear receptor coactivator family members and their role in rare fusion‑driven neoplasms (Review).Oncol Lett2024https://conductscience.org/library/papers/38572059PubMed
1031582835EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.Oncogene2020https://conductscience.org/library/papers/31582835PubMed
1115016911Metagenes and molecular pattern discovery using matrix factorization.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15016911PubMed
1219183342Array comparative genomic hybridization in retinoma and retinoblastoma tissues.Cancer Sci2009https://conductscience.org/library/papers/19183342PubMed
1310548103Learning the parts of objects by non-negative matrix factorization.Nature1999https://conductscience.org/library/papers/10548103PubMed
1440647534KDM6A Variants Increased Relapse Risk in Adult Acute Myeloid Leukemia.Cancers (Basel)2025https://conductscience.org/library/papers/40647534PubMed
1537025176Advances in holliday junction recognition protein (HJURP): Structure, molecular functions, and roles in cancer.Front Cell Dev Biol2023https://conductscience.org/library/papers/37025176PubMed
1620959668Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis.Am J Clin Pathol2010https://conductscience.org/library/papers/20959668PubMed
1736130950Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy.Nat Commun2022https://conductscience.org/library/papers/36130950PubMed
1840395327A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma.Front Oncol2025https://conductscience.org/library/papers/40395327PubMed
1916244221Improving molecular cancer class discovery through sparse non-negative matrix factorization.Bioinformatics2005https://conductscience.org/library/papers/16244221PubMed
2023498719Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.Lancet Oncol2013https://conductscience.org/library/papers/23498719PubMed

See all 85 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42606187

GET https://conductscience.org/api/papers/v1/42606187/references?page=2